Image from Google Jackets

Factors affecting the outcome of covid 19 patients with hypertension admitted in FEU-NRMF medical center from JANUARY to DECEMBER, 2021. / [investigator]: Calda, Daniele Alek L.

Contributor(s): Language: English Publication details: Fairview, Quezon City: Department of Medicine, FEU-NRMF, 2023Description: (in folder) with flash drive (soft copy)Content type:
  • text
Media type:
  • unmediated
Carrier type:
  • volume
LOC classification:
  • MED 2023 0005
Online resources: Summary: ABSTRACT: Introduction: The world has suffered from the outbreak of a pandemic caused by the severe acute respiratory syndrome coronavirus SARS-CoV-2 that causes the disease called COVID-19, first reported in Wuhan, Hubei Province, China on 31 December 2019. Interestingly, specific comorbidities associated with increased risk of infection and worse outcomes with development of increased severity of lung injury and mortality have been reported. The most common comorbidities were hypertension (30%), diabetes (19%), and coronary heart disease (8%) General Objective: To describe the outcome of COVID-19 confirmed patients with hypertension, admitted in FEU-NRMF Medical Center from January-December 2021 Methodology: Retrospective research design was used in this study. The principal investigator ensured the completeness of each medical records. An incomplete data needed for the analysis were subjected for exclusion. Data were collected via a chart review by obtaining consent Demographic profiles (age, sex, comorbidities), and clinical outcomes (number of hospital days, disposition, mortality) were obtained via chart review. Results: The majority of hypertensive patients were > 60 years old (96; 61,8%), female (81;51.6%), were overweight (66; 42%). Aside from hypertension, DM was also noted as co-morbidity (57; 36.3%). Most these patients were unvaccinated (127; 80.9%). The largest group had uncontrolled hypertension (87; 55.3%) and had hypertension for 0-5 years (54; 34.8%). COVID 19 with hypertension had an increased risk for ICU admission (OR 1.69 [95% Cl 1.3-2.2], p .000 < .05). Hypertensive patients were noted to account for the highest number of extended hospitals stay (14-21 days; 28 (17,8%) and > 21 days; 12 (7.6%), intubation (46; 29.3%), and mortality (30; 19.1%). Conclusions: Hypertension as a comorbidity, especially with no history of COVID 19 vaccination, may potentially compromise the outcome of patients. This was based on the fact that hypertensive COVID 19 patients were seen to have higher likelihood of ICU admission. Keywords: COVID 19, Hypertension, Outcome
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Call number Status Date due Barcode
Research Far Eastern University - Nicanor Reyes Medical Foundation MED 2023 0005 (Browse shelf(Opens below)) Available R000755
Browsing Far Eastern University - Nicanor Reyes Medical Foundation shelves Close shelf browser (Hides shelf browser)
No cover image available
No cover image available
No cover image available
No cover image available
No cover image available
No cover image available
No cover image available
MED 2023 0001 Knowledge, attitude, and practices of pediatric consultants in telemedicine in tertiary hospitals / [author]: Gregorio, Judith Marie D. [co-author]: Agrava, Ma. Amparo C. MED 2023 0003 A descriptive study on gaps and potential barriers palliative care service utilization among internist in FEU-NRMF medical center / [Principal investigator]: Ines, Maria Lourdes J. MED 2023 0004 Comparing chest pain scoring systems in predicting occurrence of major adverse cardiac events (MACE) among chest pain patients at the emergency department of a private tertiary hospital./ [Principal Investigator]: Gerona, Mark Ledge G. MED 2023 0005 Factors affecting the outcome of covid 19 patients with hypertension admitted in FEU-NRMF medical center from JANUARY to DECEMBER, 2021. / [investigator]: Calda, Daniele Alek L. MED 2023 0006 A descriptive study on the incidence of acute kidney injury among covid-19 patients admitted at FEU-NRMF medical center from JANUARY to DECEMBER 2021. / [principal investigator]: Caritativo, Mico Raphael MED 2023 0007 Hypothermia as neuroprotectant during acute ischemic stroke: a meta-analysis / [principal investigator]: Roxas, Gina Marie M. MED 2023 0008 A descriptive study on the incidence of autoimmune diseases in patients who had sars-cov-2 infection./ [Principal Investigator]: Yu, Kimberly S.

Includes bibliographical references.

ABSTRACT:
Introduction: The world has suffered from the outbreak of a pandemic caused by the severe acute respiratory syndrome coronavirus SARS-CoV-2 that causes the disease called COVID-19, first reported in Wuhan, Hubei Province, China on 31 December 2019. Interestingly, specific comorbidities associated with increased risk of infection and worse outcomes with development of increased severity of lung injury and mortality have been reported. The most common comorbidities were hypertension (30%), diabetes (19%), and coronary heart disease (8%)
General Objective: To describe the outcome of COVID-19 confirmed patients with hypertension, admitted in FEU-NRMF Medical Center from January-December 2021
Methodology: Retrospective research design was used in this study. The principal investigator ensured the completeness of each medical records. An incomplete data needed for the analysis were subjected for exclusion. Data were collected via a chart
review by obtaining consent Demographic profiles (age, sex, comorbidities), and clinical outcomes (number of hospital days, disposition, mortality) were obtained via chart review.
Results: The majority of hypertensive patients were > 60 years old (96; 61,8%), female (81;51.6%), were overweight (66; 42%). Aside from hypertension, DM was also noted as co-morbidity (57; 36.3%). Most these patients were unvaccinated (127; 80.9%). The largest group had uncontrolled hypertension (87; 55.3%) and had hypertension for 0-5 years (54; 34.8%). COVID 19 with hypertension had an increased risk for ICU admission (OR 1.69 [95% Cl 1.3-2.2], p .000 < .05). Hypertensive patients were noted to account for the highest number of extended hospitals stay (14-21 days; 28 (17,8%) and > 21 days; 12 (7.6%), intubation (46; 29.3%), and mortality (30; 19.1%).
Conclusions: Hypertension as a comorbidity, especially with no history of COVID 19 vaccination, may potentially compromise the outcome of patients. This was based on the fact that hypertensive COVID 19 patients were seen to have higher likelihood of ICU
admission.
Keywords: COVID 19, Hypertension, Outcome

Department of Medicine Research - Department of Medicine

There are no comments on this title.

to post a comment.